Saliva Collection Devices Market is Anticipated to Witness High Growth Owing to Rising Focus on Non-Invasive Diagnostic Testing

 

Saliva Collection Devices Market

Saliva collection devices find widespread application in diagnosis of various diseases, disorders and conditions. These devices offer a non-invasive method of sample collection and are increasingly being used for testing of diseases such as HIV, hepatitis and drug and alcohol testing. The trend towards non-invasive diagnostic testing is a major factor driving demand for saliva collection devices globally. The need for saliva collection devices arises due to various advantages associated with saliva testing over traditional blood collection methods. Saliva testing is pain-free, there are no biohazard concerns and sample collection can be carried out by non-medical personnel.

The Global Saliva Collection Devices Market is estimated to be valued at US$ 342.46 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2031.

Key Takeaways
Key players operating in the Saliva Collection Devices are IBM Corporation, Oracle Corporation, Cerner Corporation, InterSystems Corporation, Allscripts Healthcare Solutions, Red Hat, Inc. (acquired by IBM), Microsoft Corporation, GE Healthcare, Infor, Inc., Epic Systems Corporation, TIBCO Software Inc., McKesson Corporation, Dell Technologies, Informatica Corporation, Ascom Holding AG. These players are focusing on developing advanced saliva collection products and strengthening their distribution networks globally.

The increasing adoption of Saliva Collection Devices Market Size testing across various applications such as drug and alcohol testing, disease screening and forensic toxicology testing present significant growth opportunities for players in this market. Rapid and user-friendly saliva collection kits are gaining popularity.

Major players are expanding their presence in developing markets through partnerships and strategic mergers and acquisitions. For instance, agreements with regional diagnostic laboratories and drug testing organizations are helping global players enhance their accessibility.

Market drivers:
- Rising demand for non-invasive diagnostic methods is a major market driver. Saliva testing does not require venipuncture and is less stressful for patients.
- Increasing geriatric population worldwide is boosting the demand as older adults prefer non-invasive testing methods.
- Growing awareness about advantages of saliva testing such as ease of sample collection and transport is propelling the market growth.

Market restrain:
- Saliva collection kits need to be customized based on end use applications such as disease screening, drug testing. This requires huge R&D investments and increases product costs.
- Lack of adequate reimbursement policies for saliva testing in many countries is hindering market growth. Many insurers do not cover the cost of saliva test kits.


Segment Analysis
Saliva collection devices market can be segmented on the basis of product, application, end-user and geography. Based on product, the market can be bifurcated into saliva collection swabs and devices. Devices segment dominates the global market due to rising adoption of advanced products by healthcare facilities and individuals for ease of use and improved collection of saliva samples.

Based on application, the saliva collection devices market covers life sciences, clinical diagnostics and forensics. Clinical diagnostics segment led the segment in past years owing to rising demand for non-invasive collection of saliva for test and diagnosis of various diseases.

On the basis of end-user, hospitals and diagnostic laboratories segment accounted for major share of the market. Increasing number of diagnostic tests performed in hospitals and laboratories and growing adoption of advanced saliva collection devices drive the segment growth.

Global Analysis
Regionally, North America holds the largest share in global saliva collection devices market due to rising healthcare expenditure, growing geriatric population and availability of advanced products in the region. Asia Pacific is poised to witness fastest growth during the forecast period majorly driven by large patient population, increasing healthcare awareness and rising government initiatives to support digitization in healthcare across countries like India and China. Rapidly developing medical infrastructure in countries like India and China provides significant growth opportunities for market players in the region.

Explore Our More Blogs on Saliva Collection Devices Market

Comments

Post a Comment

Popular posts from this blog

Blast Chillers Market Poised to Witness High Growth Owing to Rising Focus on Food Safety

Image
  Blast Chillers Market Blast chillers, also known as shock freeze machines, are appliances used to quickly cool or freeze food items that have been cooked. Blast chillers allow rapid and accurate chilling of cooked or cooked/hot foods quickly to temperatures that inhibit the growth of harmful bacteria. This rapid chilling process helps restaurants, cafes, caterers and foodservice distributors maintain food quality as well as meet critical food safety regulations. Blast chillers help in preserving the look, texture, flavor and nutritional value of foods even after rapid chilling. They extend the shelf life of cooked foods by preventing bacterial growth in the food's temperature danger zone — between 4°C and 60°C. With increasing focus on food safety, hygiene and quality across the foodservice industry, demand for blast chillers has been rising significantly. The Global blast chillers market is estimated to be valued at US$ 2.24 Bn in 2024 and is expected to exhibit a CAGR of 15%...
Read more

Driving Forces and Strategic Insights: Unveiling Growth Opportunities in the Global Pharma 4.0 Market

Image
  Global Pharma 4.0 Market The Global Pharma 4.0 Market is witnessing unprecedented growth driven by several factors. One of the key market drivers is the increasing adoption of digitalization and automation in the pharmaceutical industry. Pharma 4.0 represents the integration of advanced technologies such as artificial intelligence, big data analytics, Internet of Things (IoT), and robotics into pharmaceutical manufacturing and supply chain processes. This integration enhances efficiency, reduces costs, and improves the quality of pharmaceutical products. Additionally, the rising demand for personalized medicine and the need for efficient drug development processes are further fueling the growth of the Global Pharma 4.0 Market. The Global Pharma 4.0 Market is estimated to be valued at   US$ 54.43 Bn in 2024 and is expected to exhibit a CAGR of 18.3% over the forecast period from 2024 to 2031.   Conducting a PEST analysis provides insights into the external facto...
Read more

Navigating Growth: Insights into the Global Flea, Tick, and Heartworm Products Market

Image
  Global Flea, Tick, and Heartworm Products Market The Global Flea, Tick, and Heartworm Products Market have witnessed robust growth in recent years, driven by several key factors. Market drivers such as increasing pet ownership, rising awareness about pet health, and the growing prevalence of flea, tick, and heartworm infections among pets are propelling the demand for related products. Furthermore, advancements in veterinary medicines and the introduction of novel products with improved efficacy are augmenting market growth. The rising disposable income and changing lifestyles, particularly in emerging economies, have also contributed significantly to the expansion of the Global Flea, Tick, and Heartworm Products Market. The Global Flea, Tick, and Heartworm Products Market is estimated to be valued at US$ 3.14 Bn in 2024 and is expected to exhibit a CAGR of 8.5% over the forecast period 2024 to 2031. Conducting a PEST analysis provides valuable insights into the external f...
Read more